MedE Special Seminar. Dr. Alex Abramson
Wearable and ingestible medical devices hold profound implications in medicine, supporting a new generation of personalized and automated therapies with higher patient compliance and faster diagnostic feedback. In this talk, we will explore a series of technologies that physically interact with targeted tissues through programmable geometric and material transformations to enable previously unachievable therapeutic and sensing capabilities. Specifically, we will review the development of novel technologies enabling the oral delivery of macromolecule drugs such as insulin, as well as technologies enabling the rapid assessment of cancer therapeutics through real-time tumor progression monitoring.
Biography: Dr. Alex Abramson is a postdoctoral fellow in Chemical Engineering at Stanford University working with Profs. Zhenan Bao and the late Sanjiv S. Gambhir. Dr. Abramson received his B.S. in Chemical and Biomolecular Engineering from Johns Hopkins University and his Ph.D. in Chemical Engineering from MIT under the direction of Profs. Robert Langer and Giovanni Traverso. His research, which focuses on oral biologic drug delivery and bioelectronic therapeutics, has been featured in news outlets such as The New York Times, NPR, and Wired. Dr. Abramson has received several recognitions for scientific innovation, including being named a member of the Forbes 30 Under 30 Science List and being named an NIH Ruth L. Kirschstein Postdoctoral Fellow. Alex is passionate about translating scientific endeavors from bench to bedside. Recently, Novo Nordisk exclusively licensed a portfolio of his patents to bring into clinical trials, and Alex serves as a scientific advisor overseeing their commercialization. In his spare time, Dr. Abramson acts as an executive member of the Stanford Chemical Engineering DEI Committee, volunteers as a STEM tutor at a local middle school, mentors start-up ventures in the biotechnology space, plays golf, and hikes. For more information about Dr. Abramson, please visit his website: www.agabramson.com.